Maya Devi Srivastava, M.D., Ph.D., P.C.
1000 Youngs Rd. Suite #208
Williamsville, NY 14221
One of the special aspects of this practice is our commitment to the advancement of knowledge and improvement in treatment of complex disorders of the gastrointestinal and immune systems. We maintain an active research lab at Buffalo General where we conduct research on the mechanisms of disease. We very frequently have research fellows who work in the lab with us on different projects. Dr. Maya Srivastava has mentored dozens of students, residents, and fellows over the years, and published many scholarly abstracts and journal articles on mucosal immunology.Presently, we are completing an IRB approved study on Mycoplasma pneumoniae infection and eosinophilic esophagitis. Dr. Manisha Relan and Dr. Katie Agnello, fellows at UB in Allergy and Immunology and Gastroenterology have been helping on this project. Approximately 100 of our patients have participated in this study so far.
In addition to lab research, patients in the practice have multiple opportunities to participate in clinical research. Nurse Carol Hammond is in charge of these studies. We are about to start a new IRB approved study on Ulcerative Colitis patients treated with the anti-TNF antibody Humira. In the past we were a study site for the use of anti-IL5 in the treatment of eosinophilic esophagitis, and a registry site for Pediatric Remicade patients.
Dr. Maya Srivastava is honored to be on the National Faculty Speaker’s Bureau for Abbvie (Humira) and Janssen (Remicade), and lectures to health care professionals all over the USA on the safe and appropriate use of these medications.
Please contact us at 716-688-0525 if you would like to learn more about our research projects or are interested in participating.